For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Map Pharmaceuticals, Inc.

USPTO Granted Patents = 33

% Expired Patents = 27.3

CIPO Patents = 1

EPO Patents = 6

Forward Citations = 312

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Robert Owen Cook (17 out of 23 patents)

Thomas A Armer (16 out of 42 patents)

Jian Zhang (14 out of 23 patents)

4. Stephen B Shrewsbury (5 out of 8 patents)

5. Nabih N Ramadan (5 out of 5 patents)

6. Neil Russell Foster (5 out of 5 patents)

7. Hubert Leonardus Regtop (5 out of 5 patents)

8. Prashant Kakade (4 out of 5 patents)

9. Fariba Dehghani (4 out of 4 patents)

10. Benjamin Stedman (2 out of 2 patents)

11. Darrell Woehler (2 out of 2 patents)

12. John Leonard (2 out of 2 patents)

13. Alfred Sugianto (2 out of 2 patents)

14. Libo Wu (2 out of 2 patents)

15. Donald J Kellerman (1 out of 1 patent)

Core Competencies:

DHE Administration

Migraine Relief

Aerosolized Medication

Inhalation Devices

Fluoroergoline Analogs

Iso-Ergoline Derivatives

Dose Counter

Neuromodulatory Compounds

Corticosteroid Particles

Particle Formation

Enhanced Eductor Design

Sedative Hypnotic Compounds

33 patents: Sort by Forward Citations

1. 10172853 - Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile (2019-01-08),

2. 9833451 - Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile (2017-12-05),

3. 9610415 - Enhanced eductor design (2017-04-04),

4. 9480803 - Dose counter with lockout mechanism (2016-11-01),

5. 9394314 - 8'-hydroxy-dihydroergotamine compounds and compositions (2016-07-19),

6. 9365591 - Fluoroergoline analogs (2016-06-14),

7. 9227030 - Enhanced eductor design (2016-01-05),

8. 9216259 - Methods and apparatus for delivering aerosolized medication (2015-12-22),

9. 9161912 - Inhalation devices and related methods for administration of sedative hypnotic compounds (2015-10-20),

10. 9150593 - Fluoroergoline analogs (2015-10-06),

11. 9012640 - Cabergoline derivatives (2015-04-21),

12. 8969374 - Iso-ergoline derivatives (2015-03-03),

13. 8946420 - Neuromodulatory compounds (2015-02-03),

14. 8933093 - Fluoroergoline analogs (2015-01-13),

15. 8895743 - Methysergide derivatives (2014-11-25),

Map Pharmaceuticals, Inc. is a biopharmaceutical company based in Irvine, California, focused on developing innovative therapies for the treatment of neurological disorders. The organization specializes in formulating and delivering novel drug products, leveraging advanced technologies to enhance therapeutic efficacy and patient compliance. With a commitment to addressing unmet medical needs, Map Pharmaceuticals aims to improve the quality of life for patients through its targeted research and development efforts in the pharmaceutical sector.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

33 Patents

#104 in Irvine, CA

#2,460 in California

#10,296 in US

#20,128 in the World

Irvine, CA, United States of America

Map Pharmaceuticals, Inc.

Forward Citations = 312

23 inventors:

Robert Owen Cook (17 out of 23 patents)

Thomas A Armer (16 out of 42 patents)

Jian Zhang (14 out of 23 patents)

4. Stephen B Shrewsbury (5 out of 8 patents)

5. Nabih N Ramadan (5 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…